Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by craighenryon Dec 16, 2022 2:26pm
71 Views
Post# 35176441

RE:RE:RE:RE:panobinostat, lomustine, xB3-bevacizumab

RE:RE:RE:RE:panobinostat, lomustine, xB3-bevacizumab
JDavenport wrote: I confess, craig, I lied. It's only 909,652,073 shares.

909,652,073 isn't even close to a billion. 

jd



Absolutely clueless JD.  

Lets see:

MTP currently has 3.94 Million shares outstanding  plus approx 76 million issued for the Bioasis merger (footnote below) 

To me that is approx. 79.4 million shares outstanding. 

No wonder DR dropped your butt.  Absolute incompetence.   She saw that a mile a way. 


John, there is a reason GD is still employed by Bioasis and you aren't!







"The Acquisition consideration will be satisfied by the issue of, in aggregate, 75,884,553 new Ordinary Shares"



<< Previous
Bullboard Posts
Next >>